
1. rev soc bras med trop. 2018 sep-oct;51(5):596-602. doi:
10.1590/0037-8682-0475-2017.

prevalence low bone mass changes vitamin levels human
immunodeficiency virus-infected adults unexposed antiretrovirals.

guimarães ns(1), guimarães mmm(2), kakehasi am(3), paula mgp(1), caporali
jfm(1)(2), vieira élm(1), tanajura pr(1), tupinambás u(1)(2).

author information: 
(1)programa de pós-graduação strictu senso em ciências da saúde: infectologia e
medicina tropical, universidade federal de minas gerais, belo horizonte, mg,
brasil.
(2)departamento de clínica médica, universidade federal de minas gerais, belo
horizonte, mg, brasil.
(3)departamento de aparelho locomotor, universidade federal de minas gerais, belo
horizonte, mg, brasil.

introduction: prevalence low bone mass 3 times higher people living 
with human immunodeficiency virus (plwh) using antiretrovirals the
hiv-unaffected population. changes vitamin levels one factors
associated decreased bone mass. objective study evaluate
the low bone mass altered vitamin levels plwh exposed 
to antiretrovirals.
methods: cross-sectional study carried hiv-infected individuals
between ages 18 55 years immediately prior start of
antiretroviral therapy specialized reference center focusing infectious
and parasitic diseases. results clinical examination (patient's weight,
height, blood pressure, clinical history), laboratory tests, x-ray
absorptiometry, collected.
results: sixty patients included, mean age 34 years. nine (16.7%) 
patients presented low bone mass 4 (7.1%) patients showed low total
femur bmd. analysis revealed 23.3% 36.7% patients deficient
and insufficient levels 25-hydroxyvitamin d3, respectively.
conclusions: study population presented compromised bone health with
low bone mineral density 25-(oh)-vitamin levels.

doi: 10.1590/0037-8682-0475-2017 
pmid: 30304264  [indexed medline]

